Innovage Holding Corp (INNV) Stock Price, Quote & News

Company Profile

InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in its homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health...

Industry: Medical Care Facilities

Sector: Healthcare

Phone: 844 803 8745

Website: www.innovage.com

Address:

8950 E. Lowry Boulevard, Denver, United States

StocktwitsEarnings Feb. 3 at 9:13 PM

$INNV Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.08 up 180.00% YoY • Reported revenue of $239.71M up 14.69% YoY • InnovAge is raising its full year fiscal 2026 financial guidance for total revenues to a range of $925 million to $950 million and Adjusted EBITDA to $70 million to $75 million, while census guidance remains unchanged.

0 · Reply

11thestate Jan. 30 at 1:08 PM

Don't forget that there is also an important settlement to watch for $INNV We have every detail, including how investors can get paid: https://11th.com/cases/innovage-investor-settlement

0 · Reply

OfficialStocktwitsUser Jan. 23 at 5:24 PM

$INNV RSI: 64.65, MACD: 0.1341 Vol: 0.26, MA20: 5.56, MA50: 5.43 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

11thestate Jan. 21 at 4:29 PM

Don't forget that there is also an important settlement to watch for $INNV We have every detail, including how investors can get paid: https://11th.com/cases/innovage-investor-settlement

0 · Reply

11thestate Jan. 9 at 11:33 AM

$INNV investors — there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more: https://11th.com/cases/innovage-investor-settlement

0 · Reply

BillionerOfKing Jan. 6 at 10:09 AM

$INNV Current Stock Price: $5.47 Contracts to trade: $5 INNV Jan 16 2026 Call Entry: $0.42 Exit: $0.79 ROI: 88% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

11thestate Dec. 26 at 3:25 PM

Imagine buying $INNV at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $INNV investors out there, we’ve got some important news for you: https://11th.com/cases/innovage-investor-settlement

0 · Reply

SouthernSeaS Dec. 25 at 9:15 AM

$INNV Capital discipline has become the critical gating factor, while management calibrates resource allocation to real demand signals. Clear follow‑through could unlock sustainable re‑rating.

0 · Reply

11thestate Dec. 15 at 2:44 PM

$INNV investors — there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more. https://11th.com/cases/innovage-investor-settlement

0 · Reply

SuperGreenToday Dec. 5 at 3:31 PM

$INNV Share Price: $5.12 Contract Selected: May 15, 2026 $5 Calls Buy Zone: $0.85 – $1.05 Target Zone: $1.44 – $1.75 Potential Upside: 60% ROI Time to Expiration: 160 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025

Jan 29, 2026, 8:00 AM EST - 5 days ago

InnovAge Expands Board with Appointment of Two Directors

AMSF

Jan 21, 2026, 8:00 AM EST - 13 days ago

InnovAge to Announce Fiscal Second Quarter 2026 Financial Results and Host Conference Call Tuesday, February 3, 2026

Jan 12, 2026, 2:55 PM EST - 22 days ago

InnovAge Holding Corp. (INNV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Dec 30, 2025, 8:00 AM EST - 5 weeks ago

InnovAge Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference

Nov 11, 2025, 3:00 PM EST - 3 months ago

InnovAge and Tampa General Hospital Celebrate Partnership of Senior Care in Grand Re-Opening

Nov 4, 2025, 9:56 PM EST - 3 months ago

InnovAge Holding Corp. (INNV) Q1 2026 Earnings Call Transcript

Nov 4, 2025, 4:05 PM EST - 3 months ago

InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2025

Nov 3, 2025, 4:05 PM EST - 3 months ago

InnovAge Appoints Dr. Paul Taheri as Chief Medical Officer

Oct 22, 2025, 4:22 PM EDT - 3 months ago

Halper Sadeh LLC Encourages InnovAge Holding Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 21, 2025, 8:00 AM EDT - 3 months ago

InnovAge to Announce Fiscal First Quarter 2026 Financial Results and Host Conference Call Tuesday, November 4, 2025

Sep 23, 2025, 8:00 AM EDT - 4 months ago

InnovAge Appoints Meredith Delk as Executive Vice President and Chief Administrative Officer

Sep 11, 2025, 11:02 AM EDT - 5 months ago

InnovAge Named as One of the Nation's Best Workplaces in Aging Services™ by Fortune® and Great Place to Work®

Sep 9, 2025, 11:49 PM EDT - 5 months ago

InnovAge Holding Corp. (INNV) Q4 2025 Earnings Call Transcript

Sep 9, 2025, 4:05 PM EDT - 5 months ago

InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2025

Aug 26, 2025, 8:00 AM EDT - 5 months ago

InnovAge to Announce Fourth Quarter and Fiscal 2025 Financial Results and Host Conference Call Tuesday, September 9, 2025

Aug 15, 2025, 4:05 PM EDT - 6 months ago

InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa

May 10, 2025, 10:45 AM EDT - 9 months ago

InnovAge Holding Corp. (INNV) Q3 2025 Earnings Call Transcript

May 6, 2025, 4:05 PM EDT - 9 months ago

InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2025

Apr 22, 2025, 8:00 AM EDT - 10 months ago

InnovAge to Announce Fiscal Third Quarter 2025 Financial Results and Host Conference Call Tuesday, May 6, 2025

Apr 17, 2025, 8:00 AM EDT - 10 months ago

InnovAge Champions PACE at State Capitols to Protect Critical Care for Seniors

Mar 4, 2025, 8:00 AM EST - 1 year ago

InnovAge Announces Participation at the KeyBanc Capital Markets Healthcare Forum

Feb 4, 2025, 11:49 PM EST - 1 year ago

InnovAge Holding Corp. (INNV) Q2 2025 Earnings Call Transcript

Feb 4, 2025, 4:05 PM EST - 1 year ago

InnovAge Announces Financial Results For the Fiscal Second Quarter Ended December 31, 2024

Jan 21, 2025, 8:00 AM EST - 1 year ago

InnovAge to Announce Fiscal Second Quarter 2025 Financial Results and Host Conference Call Tuesday, February 4, 2025

Nov 5, 2024, 11:50 PM EST - 1 year ago

InnovAge Holding Corp. (INNV) Q1 2025 Earnings Call Transcript

Nov 5, 2024, 4:05 PM EST - 1 year ago

InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2024

Nov 4, 2024, 8:00 AM EST - 1 year ago

InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services

Oct 11, 2024, 8:00 AM EDT - 1 year ago

InnovAge Provides Update on Clinical & Operational Transformations at National PACE Association Annual Conference

Sep 16, 2024, 6:19 PM EDT - 1 year ago

UPDATE – Leading PACE Provider InnovAge Selected to Participate in National Study Focused on Preventing Falls by Seniors

Sep 16, 2024, 8:00 AM EDT - 1 year ago

Leading PACE Provider InnovAge Selected to Participate in National Study Focused on Preventing Falls by Seniors

Sep 10, 2024, 7:17 PM EDT - 1 year ago

InnovAge Holding Corp. (INNV) Q4 2024 Earnings Call Transcript

Sep 10, 2024, 4:05 PM EDT - 1 year ago

InnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2024

Aug 22, 2024, 3:20 PM EDT - 1 year ago

CORRECTION -- InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center

Aug 16, 2024, 8:00 AM EDT - 1 year ago

InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center

Jun 10, 2024, 8:00 AM EDT - 1 year ago

InnovAge Holding Corp. Announces $5.0 Million Share Repurchase Program

Jun 3, 2024, 8:05 AM EDT - 1 year ago

InnovAge PACE Recertified as a Great Place to Work

May 29, 2024, 1:05 PM EDT - 1 year ago

InnovAge Celebrates Grand Opening of Orlando's First PACE Center in Partnership with Orlando Health

May 20, 2024, 8:00 AM EDT - 1 year ago

InnovAge Welcomes John Koehn as Senior Vice President of External Affairs

May 12, 2024, 8:06 AM EDT - 1 year ago

InnovAge Holding Corp. (INNV) Q3 2024 Earnings Call Transcript

Apr 24, 2024, 4:00 PM EDT - 1 year ago

InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently with High-Quality Care

Apr 23, 2024, 8:00 AM EDT - 1 year ago

InnovAge to Announce Fiscal Third Quarter 2024 Financial Results and Host Conference Call Tuesday, May 7, 2024

Mar 4, 2024, 12:50 PM EST - 2 years ago

InnovAge Launches First PACE Center in Florida Providing Comprehensive Healthcare Program for Seniors to Promote Independence

Feb 6, 2024, 8:44 PM EST - 2 years ago

InnovAge Holding Corp. (INNV) Q2 2024 Earnings Call Transcript

Feb 6, 2024, 4:05 PM EST - 2 years ago

InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2023

Jan 23, 2024, 8:00 AM EST - 2 years ago

InnovAge to Announce Fiscal Second Quarter 2024 Financial Results and Host Conference Call Tuesday, February 6, 2024

Dec 1, 2023, 9:20 AM EST - 2 years ago

InnovAge Announces Acquisition of ConcertoCare's PACE Programs

Nov 11, 2023, 5:00 PM EST - 2 years ago

InnovAge Holding Corp. (INNV) Q1 2024 Earnings Call Transcript

Oct 2, 2023, 4:15 PM EDT - 2 years ago

InnovAge Names Darlene Flaig as New Chief Nursing Officer

Sep 19, 2023, 8:33 AM EDT - 2 years ago

InnovAge Holding Corp.: Enrollment Growth Metrics Suggest Business Is Recovering Well

StocktwitsEarnings Feb. 3 at 9:13 PM

0 · Reply

11thestate Jan. 30 at 1:08 PM

Don't forget that there is also an important settlement to watch for $INNV We have every detail, including how investors can get paid: https://11th.com/cases/innovage-investor-settlement

0 · Reply

OfficialStocktwitsUser Jan. 23 at 5:24 PM

0 · Reply

11thestate Jan. 21 at 4:29 PM

Don't forget that there is also an important settlement to watch for $INNV We have every detail, including how investors can get paid: https://11th.com/cases/innovage-investor-settlement

0 · Reply

11thestate Jan. 9 at 11:33 AM

0 · Reply

BillionerOfKing Jan. 6 at 10:09 AM

0 · Reply

11thestate Dec. 26 at 3:25 PM

0 · Reply

SouthernSeaS Dec. 25 at 9:15 AM

$INNV Capital discipline has become the critical gating factor, while management calibrates resource allocation to real demand signals. Clear follow‑through could unlock sustainable re‑rating.

0 · Reply

11thestate Dec. 15 at 2:44 PM

$INNV investors — there’s no hidden secret here. Just one thing you really need to know. Here’s how to handle your losses. More importantly, how to either recover them or risk losing even more. https://11th.com/cases/innovage-investor-settlement

0 · Reply

SuperGreenToday Dec. 5 at 3:31 PM

0 · Reply

11thestate Dec. 1 at 3:44 PM

If you missed the deadline, don’t miss this update. This is probably the most useful info you’ve read in years about $INNV — how you can actually recover something: https://11th.com/cases/innovage-investor-settlement

0 · Reply

11thestate Nov. 19 at 3:02 PM

$INNV has agreed to settle with investors over claims that it misled them about the quality of care and regulatory compliance at its healthcare centers following its IPO. Who’s eligible? Anyone who purchased $INNV shares between March 4, 2021 and December 22, 2021. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? Payout per share not determined yet. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/innovage-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=11192025

0 · Reply

11thestate Nov. 11 at 7:06 PM

0 · Reply

InItToWinIt100 Nov. 7 at 8:57 PM

$INNV Running into the close! https://www.trade-ideas.com/share.php?code=DYU4gtJWRTYp3NudXQp3KJKFXE5S59JW&_gl=1

0 · Reply

11thestate Oct. 31 at 3:50 PM

InnovAge ($INNV) has reached a settlement with investors over claims that it misled them about the quality of care and regulatory compliance at its healthcare centers following its IPO. Who’s eligible? All persons who purchased or otherwise acquired InnovAge Holding Corp. common stock between March 4, 2021 and December 22, 2021, inclusive, and were damaged thereby; and all persons who purchased InnovAge common stock in or traceable to the Company’s March 4, 2021 initial public offering. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. Can I still file? Yes — investors can still file a late claim to receive payment from the InnovAge settlement. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/innovage-investor-settlement

0 · Reply

11thestate Oct. 17 at 1:26 PM

$INNV has reached a $27M settlement with $INNV investors over claims that it misled them about the quality of care and regulatory compliance at its healthcare centers following its IPO. The filing deadline is November 5, 2025. If you bought $INNV between March 4, 2021, and December 22, 2021, you can file for payment here: https://11th.com/cases/innovage-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=10162025_1

0 · Reply

11thestate Oct. 9 at 5:14 PM

$INNV has reached a $27M settlement with $INNV investors over claims it misled them about the quality of care and regulatory compliance at its healthcare centers following its IPO. The filing deadline is November 5, 2025. If you bought $INNV between March 4, 2021, and December 22, 2021, you can file for payment here: https://11th.com/cases/innovage-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=10092025_1

0 · Reply

NVDAMillionaire Oct. 3 at 8:06 PM

$INNV Excellent article that nails exactly where INNV stands right now. So if you want to update your INNV knowledge or get acquainted with INNV, this is a must read. https://beyondspx.com/quote/INNV/analysis/innovage-s-pace-power-play-expanding-margins-and-market-leadership-nasdaq-innv

0 · Reply

11thestate Sep. 29 at 6:34 PM

$INNV has reached a tentative $27M settlement with $INNV investors over claims it misled them about quality of care and regulatory compliance at its healthcare centers following its IPO. The filing deadline is November 5, 2025. If you bought $INNV between March 4, 2021, and December 22, 2021, you can file for payment here: https://11th.com/cases/innovage-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=ddl&utm_content=09292025_1

0 · Reply

11thestate Sep. 22 at 10:25 AM

$INNV has agreed to a tentative settlement with investors by paying $27 million to resolve claims that it misled them about the quality of care and regulatory compliance at its healthcare centers following its IPO. Who’s eligible? Anyone who purchased $INNV shares between March 4, 2021 and December 22, 2021. Do I need to sell my shares to qualify? No — you are eligible whether you sold your shares or still hold them. How much is the payout? Payout per share not determined yet. Can I still file? Yes — claims are currently being accepted. When do payouts happen? Typically within 8–12 months after court approval of the settlement. To file your claim: https://11th.com/cases/innovage-investor-settlement?utm_source=stocktwits&utm_medium=referral&utm_campaign=faq&utm_content=09222025_1

0 · Reply

Market Cap	753.03M
Revenue (ttm)	853.70M
Net Income (ttm)	-30.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	25.86
Profit Margin	-3.55%
Debt to Equity Ratio	0.24

Volume	184,700
Avg Vol	141,502
Day's Range	N/A - N/A
Shares Out	135.68M
Stochastic %K	40%
Beta	0.57
Analysts	Hold
Price Target	$5.25